No black box warning on record for Ellence

As of the latest FDA labeling reviewed, Ellence (EPIRUBICIN HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ellence medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Use in Patients with Hepatic Impairment: Monitor serum total bilirubin and AST levels before and during treatment with ELLENCE. In patients with elevated serum AST or serum total bilirubin, dosage reductions or discontinuation may be required ( 2.3 , 5.5 ). • Tumor Lysis Syndrome: Evaluate blood uric acid levels, potassium, calcium, phosphate, and creatinine after init

No black box warning on record for Ellence

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Use in Patients with Hepatic Impairment: Monitor serum total bilirubin and AST levels before and during treatment with ELLENCE. In patients with elevated serum AST or serum total bilirubin, dosage reductions or discontinuation may be required ( 2.3 , 5.5 ). • Tumor Lysis Syndrome: Evaluate blood uric acid levels, potassium, calcium, phosphate, and creatinine after init

Ellence Black Box Warning

No black box warning on record for Ellence

Other warnings & precautions

Ellence Black Box Warning

No black box warning on record for Ellence

Other warnings & precautions